Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL1958 Target Snapshot

3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1 · SINGLE PROTEIN · Homo sapiens

15Compounds
2Assays
1Approved Drugs
15.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt P14060. Use UniProt P14060 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P14060 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats 3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1 as ChEMBL target CHEMBL1958, mapped to UniProt P14060. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1
SINGLE PROTEIN · Homo sapiens
As of 2026-09-14
ChEMBL target ID
CHEMBL1958
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
P14060
3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether 3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1 is the right protein anchor across sources, using UniProt P14060 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein Label3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1
UniProt AccessionP14060
Component TypeProtein
Sequence Length373 aa

3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as 3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1, mapped to UniProt P14060. Sequence length is 373 aa.

Mapped IDP14060
Review name3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

1
Approved
Assay Mix

Activity Type Distribution

IC502.0
KI13.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL25516 8.11 Ki 7.8 Preclinical
CHEMBL24033 8.08 IC50 8.3 Preclinical
CHEMBL280155 8.0 Ki 10.0 Preclinical
CHEMBL297524 7.92 Ki 12.0 Preclinical
CHEMBL25183 7.72 Ki 19.0 Preclinical
CHEMBL24088 6.82 Ki 150.0 Preclinical
CHEMBL24729 6.82 IC50 150.0 Preclinical
CHEMBL283123 6.8 Ki 160.0 Preclinical
CHEMBL3085538 6.75 Ki 180.0 Preclinical
CHEMBL24291 6.72 Ki 190.0 Preclinical
Distribution

pChEMBL Value Distribution

0
5.0
1
5.5
2
6.0
6
6.5
0
7.0
2
7.5
3
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Assay Landscape

Assay Landscape

2
Total Assays
15
Tested Compounds
1
Assay Types
Binding — 2 assays, 15 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 2 15 6.9

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine